-
1
-
-
0022322074
-
The development of orphan drugs. A pharmaceutical company perspective
-
Stucki JC. The development of orphan drugs. A pharmaceutical company perspective. Prog Clin Biol Res 1985; 197: 95-104.
-
(1985)
Prog Clin Biol Res
, vol.197
, pp. 95-104
-
-
Stucki, J.C.1
-
2
-
-
12644284390
-
Health promotion and disease prevention amendments of 1984
-
Health promotion and disease prevention amendments of 1984. Public Law 98-551.
-
Public Law
, pp. 98-551
-
-
-
3
-
-
12644315919
-
The U.S. orphan drug development program: Incentives and results
-
Scheinberg IH, Walshe J.M., eds. Manchester: University Press
-
Finkel MJ. The U.S. orphan drug development program: incentives and results. In: Scheinberg IH, Walshe J.M., eds. Orphan diseases and orphan drugs. Manchester: University Press, 1986: 159-168.
-
(1986)
Orphan Diseases and Orphan Drugs
, pp. 159-168
-
-
Finkel, M.J.1
-
4
-
-
0028776178
-
Rare diseases and orphan drugs
-
Daina E. Rare diseases and orphan drugs. Lancet 1994; 343: 1560-1561.
-
(1994)
Lancet
, vol.343
, pp. 1560-1561
-
-
Daina, E.1
-
7
-
-
12644312084
-
Orphan Drug Act
-
Orphan Drug Act. Public Law 97-414, 1983.
-
(1983)
Public Law
, pp. 97-414
-
-
-
8
-
-
0026032308
-
The Orphan Drug Act. The first seven years
-
Asbury CH. The Orphan Drug Act. The first seven years. JAMA 1991; 265: 893-897.
-
(1991)
JAMA
, vol.265
, pp. 893-897
-
-
Asbury, C.H.1
-
9
-
-
0028596473
-
Orphan products. Ten years later and then some
-
Haffner ME. Orphan products. Ten years later and then some. Food Drug Law J 1994; 49: 593-601.
-
(1994)
Food Drug Law J
, vol.49
, pp. 593-601
-
-
Haffner, M.E.1
-
10
-
-
12644314062
-
Orphan products
-
Finkel MJ. 'Orphan products'. Ind Sante 1985; 103: 41.
-
(1985)
Ind Sante
, vol.103
, pp. 41
-
-
Finkel, M.J.1
-
11
-
-
0022392936
-
Orphan drugs: The question of products liability
-
Scharf SF. Orphan drugs: The question of products liability. Am J Law Med 1985; 10: 491-513.
-
(1985)
Am J Law Med
, vol.10
, pp. 491-513
-
-
Scharf, S.F.1
-
12
-
-
0023040109
-
Drugs that wouldn't die
-
Weintraub M, Northington FK. Drugs that wouldn't die. JAMA 1986; 255: 2327-2328.
-
(1986)
JAMA
, vol.255
, pp. 2327-2328
-
-
Weintraub, M.1
Northington, F.K.2
-
13
-
-
0028242592
-
Unique aspects of orphan drug safety
-
Affner ME. Unique aspects of orphan drug safety. Drug Inf J 1994; 28: 489-494.
-
(1994)
Drug Inf J
, vol.28
, pp. 489-494
-
-
Affner, M.E.1
-
14
-
-
0028239459
-
Current status of orphan disease drug development
-
Thoene JG. Current status of orphan disease drug development. Curr Opin Pediatr 1994; 6: 209-212.
-
(1994)
Curr Opin Pediatr
, vol.6
, pp. 209-212
-
-
Thoene, J.G.1
-
15
-
-
0027437241
-
The Orphan Drug Act. Should it be changed?
-
Sanders CA. The Orphan Drug Act. Should it be changed? Arch Int Med 1993; 153: 2623-2625.
-
(1993)
Arch Int Med
, vol.153
, pp. 2623-2625
-
-
Sanders, C.A.1
-
16
-
-
0027139178
-
Senators seek reform of Orphan Drug Act
-
Seachrist L. Senators seek reform of Orphan Drug Act. J Natl Cancer Inst 1993; 85: 1984-1985.
-
(1993)
J Natl Cancer Inst
, vol.85
, pp. 1984-1985
-
-
Seachrist, L.1
-
17
-
-
12644301120
-
Partial revision of the Pharmaceutical Affairs Law
-
June 4
-
Akimoto T. Partial revision of the Pharmaceutical Affairs Law. JPMA Update no 4: 3-6; June 4, 1993.
-
(1993)
JPMA Update
, vol.4
, pp. 3-6
-
-
Akimoto, T.1
-
18
-
-
12644305806
-
-
note
-
Loi du 8 décembre 1992, modifiant le livre V du code de la santé publique et relative à la pharmacie et au médicament (J.O. du 12/12/1992).
-
-
-
-
19
-
-
12644304799
-
-
note
-
Décrêt no 94-568 du 8 Juillet 1994, relatif aux autorisations temporaires d'utilisation de certains médicaments à usage humain et modifiant le code de la sante publique. (J.O. du 10/07/1994).
-
-
-
-
20
-
-
12644277301
-
Les médicaments compassionnels, orphelins et importés
-
La Loi, le médicament, le Pharmacien Hospitalier
-
Chevalier A. Les médicaments compassionnels, orphelins et importés. In: La Loi, le médicament, le Pharmacien Hospitalier. Onzième journée APHM 1994: 25-28.
-
(1994)
Onzième Journée APHM
, pp. 25-28
-
-
Chevalier, A.1
-
21
-
-
12644287459
-
-
note
-
Directive 91/507/CEE du conseil du 19 Juillet 1991 (J.O.C.E. L-214 du 26 Septembre 1991).
-
-
-
-
22
-
-
12644292826
-
Médicaments orphelins. Bientôt une politique européenne
-
Anonyme. Médicaments orphelins. Bientôt une politique européenne. D & P Actualités 1996; 7: 7-10.
-
(1996)
D & P Actualités
, vol.7
, pp. 7-10
-
-
-
23
-
-
12644253745
-
Bientôt un statut pour les orphelins?
-
Tutin C. Bientôt un statut pour les orphelins? Abstract Hôpital 1995; 52: 8-10.
-
(1995)
Abstract Hôpital
, vol.52
, pp. 8-10
-
-
Tutin, C.1
-
24
-
-
0022315211
-
Current activities and future goals of orphan disease agences
-
Van Woert MH. Current activities and future goals of orphan disease agences. Prog Clin Biol Res 1985; 197: 3-6.
-
(1985)
Prog Clin Biol Res
, vol.197
, pp. 3-6
-
-
Van Woert, M.H.1
-
25
-
-
12644296910
-
Biotechnology receives special attention in budget
-
Miller D. Biotechnology receives special attention in budget. PMA Newslett 1990; 32: 3.
-
(1990)
PMA Newslett
, vol.32
, pp. 3
-
-
Miller, D.1
-
26
-
-
0025869216
-
Replacement therapy for inherited enzyme deficiency-macrophage-targeted glucocerebrosidase for Gaucher's disease
-
Barton NW, Brady RO, Dambrosia JM et al. Replacement therapy for inherited enzyme deficiency-macrophage-targeted glucocerebrosidase for Gaucher's disease. N Engl J Med 1991; 324: 1464-1470.
-
(1991)
N Engl J Med
, vol.324
, pp. 1464-1470
-
-
Barton, N.W.1
Brady, R.O.2
Dambrosia, J.M.3
-
27
-
-
0026441201
-
No price too high?
-
Garber AM. No price too high? N Engl J Med 1992; 327: 1676-1678.
-
(1992)
N Engl J Med
, vol.327
, pp. 1676-1678
-
-
Garber, A.M.1
-
28
-
-
12644283455
-
-
Office of Technology Assessment, U.S. Congress. Washington, DC: Government Printing Office
-
Garber AM, Clarke AE, Goldman DP, Gluck ME. Federal and private roles in the development and provision of alglucerase therapy for Gaucher disease. Office of Technology Assessment, U.S. Congress. Washington, DC: Government Printing Office, 1992.
-
(1992)
Federal and Private Roles in the Development and Provision of Alglucerase Therapy for Gaucher Disease
-
-
Garber, A.M.1
Clarke, A.E.2
Goldman, D.P.3
Gluck, M.E.4
-
29
-
-
0029101015
-
Dornase-alpha and orphan drugs
-
Collier J. Dornase-alpha and orphan drugs. Lancet 1995; 346: 633.
-
(1995)
Lancet
, vol.346
, pp. 633
-
-
Collier, J.1
-
30
-
-
0024961138
-
Big first scored with nerve diseases
-
Lewin R. Big first scored with nerve diseases. Science 1989; 345: 467.
-
(1989)
Science
, vol.345
, pp. 467
-
-
Lewin, R.1
-
31
-
-
33947733705
-
Buying into the orphan drug market
-
Anonymous. Buying into the orphan drug market. Lancet 1995; 346 (8980): 917.
-
(1995)
Lancet
, vol.346
, Issue.8980
, pp. 917
-
-
-
34
-
-
0024446283
-
Human growth hormone is not an orphan
-
Frasier D. Human growth hormone is not an orphan. N Engl J Med 1989; 321: 1124.
-
(1989)
N Engl J Med
, vol.321
, pp. 1124
-
-
Frasier, D.1
-
35
-
-
12644266261
-
-
Amgen, Inc. v Chugai Pharmaceutical Company and Genetics Institute, 1989, WL 169006 (D Mass) and 13 USPQ 2, 1737
-
Amgen, Inc. v Chugai Pharmaceutical Company and Genetics Institute, 1989, WL 169006 (D Mass) and 13 USPQ 2, 1737.
-
-
-
-
36
-
-
12644280741
-
-
note
-
Hearings before the House Subcommittee on Health and the Environment, 101st Cong., 2nd Sess. (February 7, 1990) (Testimony of Thomas Wiggans).
-
-
-
-
37
-
-
0024025761
-
Are orphan products program funds underused by nuclear medicine reseachers?
-
Harby K. Are orphan products program funds underused by nuclear medicine reseachers? J Nucl Med 1988; 29: 1011-1012.
-
(1988)
J Nucl Med
, vol.29
, pp. 1011-1012
-
-
Harby, K.1
-
38
-
-
0028330887
-
Drugs bill to rein in profits
-
Gershon D. Drugs bill to rein in profits. Nature 1994; 368: 381.
-
(1994)
Nature
, vol.368
, pp. 381
-
-
Gershon, D.1
-
39
-
-
0028788896
-
The economics of orphan drug policy in the US: Can the legislation be improved?
-
Peabody JW. Ruby A, Cannon P. The economics of orphan drug policy in the US: can the legislation be improved? Pharmacoeconomics 1995; 8: 374-384.
-
(1995)
Pharmacoeconomics
, vol.8
, pp. 374-384
-
-
Peabody, J.W.1
Ruby, A.2
Cannon, P.3
-
40
-
-
0027848806
-
The orphan drug regulation and related issues
-
Levitt JA, Kelsey JV. The orphan drug regulation and related issues. Food Drug Law J 1993; 48: 525-532.
-
(1993)
Food Drug Law J
, vol.48
, pp. 525-532
-
-
Levitt, J.A.1
Kelsey, J.V.2
|